"Central America Pharmaceuticals & Healthcare Report Q3 2015" now available at Fast Market Research

Favourable tax incentives, continued demand for both generic and patented medicines, and regional anti-counterfiet measures solidify Central America's revenue generating opportunities for multinational pharmaceutical companies in coming years. Despite political instability in some areas of the region, Central America's medicine consumption will continue to grow in 2015.

Headline Expenditure Projections

* Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +4.1%. Our forecast has been maintained since Q 2 15 .
* Healthcare: USD16.8bn in 2014 to USD17.8bn in 2015; +5.1%. Our forecast has been revised upwards since Q 2 15 due to revised historical data.

Risk/Reward Index

Based on our analysis and assessment of the market's appeal to pharmaceutical companies in our Q315 Pharmaceutical Risk/Reward Index (RRIs), the Americas scores 49.7 out of 100, below Western Europe (66.8), Asia Pacific (52.7), and Central and Eastern Europe (49.5), but above the Middle East and Africa (41.7). Of the six Central American countries surveyed Costa Rica's RRI score ranks first at 44.4, followed by Panama (44), Guatemala (40), Nicaragua (35.5), El Salvador (35.0), and Honduras (33.4).

Full Report Details at
- http://www.fastmr.com/prod/987546_central_america.aspx?afid=301

Key Trends And Developments

February 2015

* The Ministries of Health of Panama and Costa Rica have entered a binational agreement to improve the access to universal health coverage on both sides of the border on February 25. The agreement aims to enhance health coverage in the border area, especially among the migrant population. It also aims to improve the availability of basic health necessities to curb epidemics such as leptospirosis, dengue and chikungunya.

March 2015

* Japan entered two cooperation agreements with Honduras and El Salvador in order to invest in the respective countries healthcare systems. The investments will be used, predominantly, to improve healthcare infrastructure.

April 2015

* Nicaragua joined the Bolivarian Alliance for the Peoples of Our America (ALBA)'s...

The Central America Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Central America Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Panama, Guatemala, Nicaragua, El Salvador, Costa Rica, Belize, Honduras pharmaceutical and healthcare industry.

Key Benefits

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Croatia Pharmaceuticals & Healthcare Report Q3 2015
- Mexico Pharmaceuticals & Healthcare Report Q3 2015
- Nigeria Pharmaceuticals & Healthcare Report Q3 2015
- Thailand Pharmaceuticals & Healthcare Report Q3 2015
- Australia Pharmaceuticals & Healthcare Report Q3 2015